Skip to content

Transcutaneous Electrical Acupoint Stimulation at PC6 as an Adjunct to Pharmacotherapy for Preventing Nausea and Vomiting after Painless Bronchoscopy in High-Risk Patients

Transcutaneous Electrical Acupoint Stimulation at PC6 as an Adjunct to Pharmacotherapy for Preventing Nausea and Vomiting after Painless Bronchoscopy in High-Risk Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000270
Enrollment
Unknown
Registered
2026-02-03
Start date
2026-02-08
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative nausea and vomiting

Interventions

Control group:Dexamethasone + tropisetron
Experimental group :Dexamethasone + tropisetron + PC6 Transcutaneous Electrical Acupoint Stimulation

Sponsors

People's Hospital of Ningxia Hui Autonomous Region
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) Aged 18 to 85 years old, no gender limit; (2) ASA classification 1-III; (3) Patients who plan to undergo electronic bronchoscopy under general anesthesia; (4) Patients with intermediate- to high-risk PONV assessed according to the Apfel simplified scoring system (Apfel score = 2 points); (5) Sign the informed consent form before surgery and be willing to participate in this study; (6) There is no serious clinical dysfunction of heart, liver, kidney and other organs; (7) No history of drug allergy, especially allergy to dexamethasone, tropisetron or electrical stimulation equipment.

Exclusion criteria

Exclusion criteria: (1)Pregnant or lactating women; There are serious cardiovascular diseases (such as severe arrhythmia, heart failure, etc.); (2) There is a history of severe allergic reactions in the past (especially drug allergies); (3) Suffering from severe mental illness or cognitive impairment, unable to understand the research content or answer related questions; (4) Patients who are contraindicated to electrical stimulation of the Neiguan acupoint or other acupuncture treatments; (5) Patients with preoperative esophageal or gastric diseases that may affect PONV assessment (such as gastroesophageal reflux disease, severe gastric ulcers, etc.); (6) There is a history of gastrointestinal surgery before the operation or other diseases that may affect postoperative nausea and vomiting; (7) Other circumstances where clinical judgment makes participation in this study unsuitable.

Design outcomes

Primary

MeasureTime frame
The incidence of Postoperative nausea and vomiting within 24 hours after surgery.;

Secondary

MeasureTime frame
The severity of nausea and vomiting at 2 hours, 6 hours and 24 hours after the operation;The usage rate of remedial antiemetic drugs;post-anesthetic care unit (PACU) stay;Postoperative discomfort complaints (such as headache, drowsiness);Patient satisfaction score;General Information;Subjects' heart rate, systolic blood pressure, diastolic blood pressure, mean arterial pressure, pulse oxygen saturation;

Countries

China

Contacts

Public ContactZhu Xiaoning

People's Hospital of Ningxia Hui Autonomous

zxn0951@sina.com+86 138 9509 5081

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Mar 14, 2026